Muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes

被引:19
作者
Bronzetti, E [1 ]
Adani, O [1 ]
Amenta, F [1 ]
Felici, L [1 ]
Mannino, F [1 ]
Ricci, A [1 ]
机构
[1] UNIV CAMERINO,IST FARMACOL,SEZ ANAT UMANA,I-62032 CAMERINO,ITALY
关键词
muscarinic cholinergic receptors; M(2) receptor; M(3) receptor; M(4) receptor; human lymphocyte; radioligand binding;
D O I
10.1016/0304-3940(96)12567-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The subtypes of muscarinic cholinergic receptors were studied in human peripheral blood lymphocytes with radioligand binding techniques and the non-selective muscarinic cholinergic receptor antagonist [H-3]quinuclidinyl benzylate (QNB) as a ligand. [H-3]QNB was bound to human peripheral lymphocytes in a manner consistent with the labelling of muscarinic cholinergic receptors, The dissociation constant (K-d) value was 0.60 +/- 0.08 nM and the maximum density of binding sites (B-max) was 2.33 +/- 0.03 fmol/2.2 x 10(6) cells. The binding was time-, temperature- and concentration-dependent, belonging to a single class of high affinity sites. Analysis of the pharmacological profile of [H-3]QNB binding in the presence of compounds specific for the different muscarinic receptor subtypes suggests that human peripheral blood lymphocytes express mainly muscarinic cholinergic M(2) and M(3) receptor subtypes and to a lesser extent muscarinic M(4) receptors. The characterization of the subtypes of muscarinic cholinergic recognition sites expressed by human peripheral blood lymphocytes may represent a tool for investigating the possible relationships between immune and cholinergic systems in normal and pathologic conditions.
引用
收藏
页码:211 / 215
页数:5
相关论文
共 28 条
[11]  
COSTA P, 1994, J NEUROIMMUNOL, V49, P113
[12]   PIRENZEPINE DISTINGUISHES BETWEEN DIFFERENT SUBCLASSES OF MUSCARINIC RECEPTORS [J].
HAMMER, R ;
BERRIE, CP ;
BIRDSALL, NJM ;
BURGEN, ASV ;
HULME, EC .
NATURE, 1980, 283 (5742) :90-92
[13]   IMMUNE SYSTEM-ASSOCIATED ANTIGENS ON THE SURFACE OF PERIPHERAL-BLOOD LYMPHOCYTES IN PATIENTS WITH ALZHEIMERS-DISEASE [J].
IKEDA, T ;
YAMAMOTO, K ;
TAKAHASHI, K ;
YAMADA, M .
ACTA PSYCHIATRICA SCANDINAVICA, 1991, 83 (06) :444-448
[14]   PRIMARY STRUCTURE OF PORCINE CARDIAC MUSCARINIC ACETYLCHOLINE-RECEPTOR DEDUCED FROM THE CDNA SEQUENCE [J].
KUBO, T ;
MAEDA, A ;
SUGIMOTO, K ;
AKIBA, I ;
MIKAMI, A ;
TAKAHASHI, H ;
HAGA, T ;
HAGA, K ;
ICHIYAMA, A ;
KANGAWA, K ;
MATSUO, H ;
HIROSE, T ;
NUMA, S .
FEBS LETTERS, 1986, 209 (02) :367-372
[15]   PARA-FLUORO-HEXAHYDRO-SILA-DIFENIDOL - THE 1ST M2-BETA-SELECTIVE MUSCARINIC ANTAGONIST [J].
LAMBRECHT, G ;
FEIFEL, R ;
FORTH, B ;
STROHMANN, C ;
TACKE, R ;
MUTSCHLER, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 152 (1-2) :193-194
[16]  
LANE MA, 1988, J NATL CANCER I, V61, P923
[17]   PHARMACOLOGICAL CHARACTERIZATION OF GUANINE-NUCLEOTIDE EXCHANGE-REACTIONS IN MEMBRANES FROM CHO CELLS STABLY TRANSFECTED WITH HUMAN MUSCARINIC RECEPTORS M1-M4 [J].
LAZARENO, S ;
FARRIES, T ;
BIRDSALL, NJM .
LIFE SCIENCES, 1993, 52 (5-6) :449-456
[18]  
LAZARENO S, 1990, MOL PHARMACOL, V38, P805
[19]  
MASLINSKI W, 1989, Brain Behavior and Immunity, V3, P1
[20]   DIRECT LABELING OF RAT M3-MUSCARINIC RECEPTORS BY [H-3] 4DAMP [J].
MICHEL, AD ;
STEFANICH, E ;
WHITING, RL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (03) :459-466